Halozyme Therapeutics, Inc. · Healthcare · Biotechnology
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$66.64
−$1.41 (−2.07%) 4:00 PM ET
Prev closePrevC$68.05
OpenOpen$67.95
Day highHigh$68.80
Day lowLow$66.44
VolumeVol1,565,300
Avg volAvgVol1,472,097
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$8.06B
P/E ratio
25.93
FY Revenue
$1.40B
EPS
2.57
Gross Margin
83.62%
Sector
Healthcare
AI report sections
MIXED
HALO
Halozyme Therapeutics, Inc.
Halozyme Therapeutics combines solid double-digit share price appreciation over the past year with bullish technical signals above key moving averages. The company’s high-margin, cash-generative business supports elevated returns on capital, while meaningful leverage and notable short interest introduce balance-sheet and sentiment-related risks. Valuation appears moderate relative to earnings and free cash flow but is rich versus book value and accompanied by a high debt-to-equity ratio.
AI summarized at 2:18 PM ET, 2026-02-03
AI summary scores
INTRADAY:72SWING:78LONG:83
Volume vs average
Intraday (cumulative)
+58% (Above avg)
Vol/Avg: 1.58×
RSI
57.69(Neutral)
Neutral (40–60)
0255075100
MACD momentum
Intraday
-0.01 (Weak)
MACD: -0.00 Signal: 0.01
Short-Term
+0.80 (Strong)
MACD: -0.02 Signal: -0.82
Long-Term
+0.63 (Strong)
MACD: -1.55 Signal: -2.18
Intraday trend score
70.60
LOW59.60HIGH95.10
Latest news
HALO•No articles found.
News is temporarily unavailable.
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal
